Target intelligence / Profile preview

egl-9 family hypoxia-inducible factor 3 pseudogene 1 (EGLN3P1)

Target
EGLN3P1
Molecular classification
Pseudogene
01

Overview

EGLN3P1, or egl-9 family hypoxia-inducible factor 3 pseudogene 1, is a genetic locus classified as a pseudogene, related to but distinct from the protein-coding EGLN3 gene. Pseudogenes are similar to functional genes but are typically non-coding and lack conventional biological activity. EGLN3P1 is not known to encode any active protein, does not serve as a receptor or enzyme, and is not a direct target for drug development. While some pseudogenes have been implicated in RNA-based regulation or as possible disease biomarkers, there is no current evidence tying EGLN3P1 to such roles. Its designation as a pseudogene indicates it is not druggable and does not possess classic molecular or functional attributes of therapeutic targets[4][6].

Other names
EGLN3 pseudogene 1egl-9 family hypoxia-inducible factor 3 pseudogene 1100420503 (NCBI Gene accession)
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on egl-9 family hypoxia-inducible factor 3 pseudogene 1 (EGLN3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on egl-9 family hypoxia-inducible factor 3 pseudogene 1 (EGLN3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call